Literature DB >> 21930552

False-positive newborn screening result and future health care use in a state Medicaid cohort.

Beth A Tarini1, Sarah J Clark, Subra Pilli, Kevin J Dombkowski, Steven J Korzeniewski, Acham Gebremariam, Jon Eisenhandler, Violanda Grigorescu.   

Abstract

OBJECTIVE: To compare health care visit rates between infants with false-positive and those with normal newborn screening (NBS) results. PATIENTS AND METHODS: We analyzed administrative claims of Medicaid-enrolled infants born in Michigan in 2006 and calculated the average number of outpatient, emergency department, and hospital visits for infants aged 3 to 12 months according to NBS results. We calculated an adjusted incidence rate ratio for each visit category, adjusting for covariates and accounting for interaction effects.
RESULTS: Of the 49,959 infants in the analysis, 818 had a false-positive NBS result. We noted a significant interaction between gestational age and NBS results. We found that preterm, but not term, infants with false-positive results had more acute outpatient visits than their counterparts with normal NBS results. We found no difference in adjusted rates of other visit types (emergency department, inpatient, outpatient well) between infants with false-positive and normal NBS results, regardless of gestational age.
CONCLUSIONS: Increased rates of acute outpatient visits among preterm infants with false-positive NBS screening results may be attributable to underlying chronic illness or parental anxiety. The absence of increased health care utilization among term infants may be unique to this Medicaid population or a subgroup phenomenon that was not detectable in this analysis.

Entities:  

Mesh:

Year:  2011        PMID: 21930552      PMCID: PMC3182843          DOI: 10.1542/peds.2010-2448

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  16 in total

1.  Annual report on access to and utilization of health care for children and youth in the United States--1999.

Authors:  M C McCormick; B Kass; A Elixhauser; J Thompson; L Simpson
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

2.  Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects.

Authors:  M F Browning; C Larson; A Strauss; D L Marsden
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.

Authors:  Beth A Tarini; Dimitri A Christakis; H Gilbert Welch
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

4.  Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests.

Authors:  Linda D Cameron; Kerry A Sherman; Theresa M Marteau; Paul M Brown
Journal:  Health Psychol       Date:  2009-05       Impact factor: 4.267

5.  Identifying and classifying children with chronic conditions using administrative data with the clinical risk group classification system.

Authors:  John M Neff; Virginia L Sharp; John Muldoon; Jeff Graham; Jean Popalisky; James C Gay
Journal:  Ambul Pediatr       Date:  2002 Jan-Feb

6.  Iatrogenesis: the PKU anxiety syndrome.

Authors:  M B Rothenberg; E M Sills
Journal:  J Am Acad Child Psychiatry       Date:  1968-10

7.  The morbidity of cardiac nondisease in schoolchildren.

Authors:  A B Bergman; S J Stamm
Journal:  N Engl J Med       Date:  1967-05-04       Impact factor: 91.245

8.  Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program.

Authors:  T H Zytkovicz; E F Fitzgerald; D Marsden; C A Larson; V E Shih; D M Johnson; A W Strauss; A M Comeau; R B Eaton; G F Grady
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

9.  Profile of medical charges for children by health status group and severity level in a Washington State Health Plan.

Authors:  John M Neff; Virginia L Sharp; John Muldoon; Jeff Graham; Kristin Myers
Journal:  Health Serv Res       Date:  2004-02       Impact factor: 3.402

10.  Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress.

Authors:  Susan E Waisbren; Simone Albers; Steve Amato; Mary Ampola; Thomas G Brewster; Laurie Demmer; Roger B Eaton; Robert Greenstein; Mark Korson; Cecilia Larson; Deborah Marsden; Michael Msall; Edwin W Naylor; Siegfried Pueschel; Margretta Seashore; Vivian E Shih; Harvey L Levy
Journal:  JAMA       Date:  2003-11-19       Impact factor: 56.272

View more
  8 in total

1.  Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles.

Authors:  Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2012-01-29       Impact factor: 10.793

Review 2.  Ethical issues with newborn screening in the genomics era.

Authors:  Beth A Tarini; Aaron J Goldenberg
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-05-01       Impact factor: 8.929

3.  Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.

Authors:  Brian Kirmse; Tzy-Jyun Yao; Sean Hofherr; Deborah Kacanek; Paige L Williams; Charlotte V Hobbs; Rohan Hazra; William Borkowsky; Russell B Van Dyke; Marshall Summar
Journal:  AIDS Res Hum Retroviruses       Date:  2016-01-19       Impact factor: 2.205

4.  Capturing the clinical utility of genomic testing: medical recommendations following pediatric microarray.

Authors:  Robin Z Hayeems; Ny Hoang; Sebastien Chenier; Dimitri J Stavropoulos; Shuye Pu; Rosanna Weksberg; Cheryl Shuman
Journal:  Eur J Hum Genet       Date:  2014-12-10       Impact factor: 4.246

5.  Postanalytical tools improve performance of newborn screening by tandem mass spectrometry.

Authors:  Patricia L Hall; Gregg Marquardt; David M S McHugh; Robert J Currier; Hao Tang; Stephanie D Stoway; Piero Rinaldo
Journal:  Genet Med       Date:  2014-05-29       Impact factor: 8.822

6.  Critical congenital heart disease screening by pulse oximetry in a neonatal intensive care unit.

Authors:  V Manja; B Mathew; V Carrion; S Lakshminrusimha
Journal:  J Perinatol       Date:  2014-07-24       Impact factor: 2.521

7.  The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study.

Authors:  Maria D Karaceper; Pranesh Chakraborty; Doug Coyle; Kumanan Wilson; Jonathan B Kronick; Steven Hawken; Christine Davies; Marni Brownell; Linda Dodds; Annette Feigenbaum; Deshayne B Fell; Scott D Grosse; Astrid Guttmann; Anne-Marie Laberge; Aizeddin Mhanni; Fiona A Miller; John J Mitchell; Meranda Nakhla; Chitra Prasad; Cheryl Rockman-Greenberg; Rebecca Sparkes; Brenda J Wilson; Beth K Potter
Journal:  Orphanet J Rare Dis       Date:  2016-02-03       Impact factor: 4.123

8.  Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates.

Authors:  Dale L Bodian; Elisabeth Klein; Ramaswamy K Iyer; Wendy S W Wong; Prachi Kothiyal; Daniel Stauffer; Kathi C Huddleston; Amber D Gaither; Irina Remsburg; Alina Khromykh; Robin L Baker; George L Maxwell; Joseph G Vockley; John E Niederhuber; Benjamin D Solomon
Journal:  Genet Med       Date:  2015-09-03       Impact factor: 8.822

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.